Silicon Fens shorts: Cox Comms signs up with Autonomy; Cambridge Consultants see Europe as first beneficiary of new consumer diagnostics
Autonomy Corporation plc, specialists in infrastructure software for the enterprise, said it has entered into a license agreement with Cox Communications to license Autonomy software.
Cox Communications is a multi-service broadband communications and entertainment company with more than 6m residential and commercial customers. The third-largest cable television company in the US, Cox offers an array of advanced digital video, high-speed Internet and telephony services over its own nationwide IP network, as well as integrated wireless services in affiliation with Sprint.
+ + +
Nujira, a company leading the development of energy efficient, high efficiency power amplifier technology for next generation wireless networks and devices, appointed Jim Brewington as Advisor to the board of directors.
“Jim is an industry veteran with unrivalled knowledge and experience of the global communications market,” CEO Tim Haynes (pictured) said. “He is a highly respected expert in the wireless industry and a very welcome addition to Nujira. Jim’s extensive career with Lucent and deep understanding of the wireless infrastructure industry will be invaluable as Nujira forges forward to becoming a market leader in high efficiency power amplifier technology for next generation wireless networks and devices. “
+ + +
DisplayLink and Alereon announced the availability of a reference design for a Wireless USB display adapter that allows PCs to connect to nearby standard displays without wires while delivering good image quality and instantaneously interactive performance.
The reference design enables PC accessory OEMs to easily develop wireless display connectivity adapters and similar products.
+ + +
Europe will be the first to reap the benefit from the consumer diagnostics revolution. However the driver for the explosion of the market will come predominantly from the US, concludes a two-part report by Cambridge Consultants that polled opinion from 32 pharmaceutical and diagnostic experts in the US and Europe.
In Europe, and particularly countries with a state run healthcare system, the industry’s growth will occur to reduce pressure on the health service. Experts in the U.S., however, believed the driver for growth in their home market would come from a combination of the growing knowledge of the population, particularly amongst the ‘internet generation’, and the country’s healthcare reimbursement practice. However, the market growth in the USA will be limited by FDA regulations, taking an expected three to five years for diagnostics product approval.
Dr Simon Burnell, head of Cambridge Consultants’ diagnostics group said, “Worldwide, the industry hasn’t fundamentally changed since the late eighties and most of the current emphasis is still on glucose and pregnancy tests. But with advances in technology coupled with increased consumer demand for information, we could be on the verge of an explosive new market in consumer-based diagnostic products.
11th December 2007
